Molecular Characterization of Carbapenemase-Producing Enterobacterales

Bacterial infections with carbapenem resistant pathogens are one of the major threats in immunocompromised patients, especially among cancer patients .Furthermore, Gram negative pathogens are becoming increasingly prevalent and have become an ongoing global health concern .Emergence of Gram-negative pathogens, especially Enterobacterales that avert many of the human defense mechanisms are alarmingly increasing and most of these pathogens are resistant to many of the in-use antibiotics including carbapenems .

NCT Number	NCT07116356
Lead Sponsor	Sohag University
Conditions	Acute Myeloid Leukemia
Enrollment	100 participants
Start Date	2025-09-10
Primary Completion	2025-09-30 (estimated)
Study Completion	2026-02-20 (estimated)
Updated on ClinicalTrials.gov	2025-08-11